San Francisco-based wearable technology company Oura has agreed to acquire AI-powered primary care company Counsel Health for $625 million in cash, expanding its business beyond health tracking into clinical care.
The acquisition, according to a Nov. 10 news release, will combine Oura’s continuous biometric monitoring technology with Counsel’s medical AI platform and physician network, allowing users to access medical advice, diagnoses, prescriptions and referrals through the Oura app.
Counsel combines medical AI with board-certified physicians to provide on-demand care. Its platform uses specialized AI agents for tasks including medical history-taking, reviewing patient records, retrieving clinical guidelines and detecting emergencies.
Patients can begin by interacting with Counsel’s AI, which draws on medical records, previous conversations, clinical guidelines and biometric data to provide personalized guidance. When additional clinical judgment is needed, patients can connect with a physician who can provide diagnoses, prescriptions and referrals.
Oura and Counsel had an existing partnership to bring AI-assisted medical guidance and physician access into the Oura app.
Following the acquisition, the companies plan to expand their work across preventive care, acute care and chronic disease management, including reproductive health, aging and cardiometabolic conditions.
Counsel will also continue serving its existing and new enterprise partners, including health systems, health plans, employers and consumer health organizations. The company uses an AI-powered clinical interface that summarizes patient records and longitudinal health trends to support physician decision-making.
Oura has more than 6 million members worldwide.
The transaction is expected to close before the end of 2026, subject to customary closing conditions.
